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An abundant human papillomavirus (HPV) protein E1^E4 is expressed late in the virus life cycle in the terminally differentiated layers of
epithelia. The expression of E1^E4 usually coincides with the onset of viral DNA amplification. However, the function of E1^E4 in viral life cycle
is not completely understood. To examine the role of E1^E4 in the virus life cycle, we introduced a single nucleotide change in the HPV-11
genome to result in a truncation of E1^E4 protein without affecting the E2 amino acid sequence. This mutated HPV-11 genome was introduced
into a human foreskin keratinocyte cell line immortalized by the catalytic subunit of human telomerase, deficient in p16INK4a expression, and
previously shown to support the HPV-11 life cycle when grown in organotypic raft culture. We have demonstrated that E1^E4 is dispensable for
HPV-11 viral DNA amplification in the late stages of the viral life cycle.
© 2006 Elsevier Inc. All rights reserved.Keywords: Human papillomavirus type 11; Organotypic raft culture; E1^E4Introduction
Human papillomaviruses (HPV) are small DNA tumor
viruses that are epitheliotropic and can cause benign or
malignant epithelial lesions at various sites (Shah and Howley,
1996). More than 200 different HPVs have been identified, and
they can also be classified into two groups according to the
route of infection (de Villiers, 2001). Cutaneous HPV, such as
HPV-1, infect cutaneous epithelia, and mucosal HPV, such as
HPV-11 and HPV-16, infect mucosal epithelium, for these two
types, mucosa of the anogenital tract. Anogenital-associated
HPV are further classified into two groups based on their
oncogenic potential as either low or high risk types (de Villiers,
2001). HPV-6 and HPV-11 are prototypes of the low risk group,
which are found primarily in benign, low-grade genital lesions
at mucosal sites, known as warts or condylomata, and in some
cases at cutaneous sites (Ko and Chu, 2004). HPV-16 and HPV-
18 are prototypes of the high risk group, which are found⁎ Corresponding author. Fax: +1 215 895 1273.
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doi:10.1016/j.virol.2006.01.051predominantly in high-grade cervical dysplasias and cervical
carcinomas (Shah and Howley, 1996).
Despite the differences in tissue tropism and the severity of
the epithelial lesions that various HPVs cause, many common
characteristics and events in the viral life cycles are shared
among various HPVs. The HPV viral life cycle is tightly linked
to the differentiation program of keratinocytes, and productive
infection is limited to the terminally differentiated keratinocytes
(Howley, 1996). HPV is thought to initially infect stem cells or
transit amplifying cells in the basal layer of the epithelium.
Following virus entry into basal epithelial cells, HPV genomes
are initially amplified as episomes to approximately 50–100
copies per cell with low levels of HPV early gene expression
(Stubenrauch and Laimins, 1999). Productive replication of the
viral genome then occurs, and viral DNA amplifies to a high
level of approximately 1000 copies per cell with epithelial cell
differentiation and migration towards epithelial cell surface
(Stubenrauch and Laimins, 1999). Viral DNA amplification is
usually followed by viral capsid antigen synthesis and assembly
of the progeny virion in the terminally differentiated epithelial
layers (Peh et al., 2002).
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the E4 open reading frames (ORFs). Codons for the first 5
amino acids are from the E1 ORF, and the remaining amino
acids are from the E4 ORF. E1^E4 is the most abundant viral
gene product constituting approximately 90% of viral tran-
scripts in genital condylomata. In experimentally generated
human papillomas arising from HPV-11-infected foreskin
xenografts, over 80% of total viral transcripts represent the
predominant E1^E4 transcripts (Fecile, 1995). However, the
role of E1^E4 in the papillomavirus life cycle remains
speculative. Although the E1^E4 protein shows little conser-
vation among HPV types, E1^E4 expression occurs in the upper
layers of differentiated epithelia and its expression coincides
with the onset of viral DNA amplification and occurs before and
with the expression of viral capsid proteins (Doorbar et al.,
1997; Middleton et al., 2003; Peh et al., 2002). A role of E1^E4
in the productive stage of viral life cycle has been suggested.
However, despite the correlation of E1^E4 expression and the
onset of viral DNA amplification, which occurs in the nucleus,
E1^E4 is mainly located in the cytoplasm (Doorbar et al., 1997).
E1^E4 has also been shown to interact with cellular keratins
when expressed in cultured epithelial cells and result in collapse
of the epithelial cell intermediate filament network (Doorbar et
al., 1991). The N-terminal leucine-rich motif is thought to be
important for the mucosal types of HPV E1^E4 association with
cellular keratin (Roberts et al., 1994; Wang et al., 2004), and the
association suggested a role in inhibition of keratin dynamics
and the sequestering of E1^E4's cellular targets in the
cytoplasm (Wang et al., 2004). A physical interaction of
HPV-16 E1^E4 through its C-terminus and a novel cellular
protein, E4-DEAD box protein (E4-DBP), has also been
demonstrated (Doorbar et al., 2000). Members of the DEAD
box protein family, to which E4-DBP belongs, are typically
involved in the regulation of mRNA stability, suggesting that
HPV-16 E1^E4 may play a role in the post-transcriptional
regulation of viral gene expression. HPV-11 E^E4 protein has
also been shown to associate with the cornified cell envelope
(Bryan and Brown, 2000), suggesting that E1^E4 may aid in the
release and spread of infectious viruses. HPV-16, 18 and 11
E1^E4 can also mediate G2 cell cycle arrest in cervical cancer
cells, and the proline-rich region of the protein is important for
the arrest (Davy et al., 2002; Nakahara et al., 2002). HPV-16
E1^E4-induced G2 arrest is associated with cytoplasmic
retention of active cdk1/cyclin B complex (Davy et al., 2005).
Recently, HPV16 E1^E4 has been shown to associate with
mitochondria and cause severely reduction of the mitochondrial
membrane potential and an induction of apoptosis (Raj et al.,
2004). However, the significance for the associations of E1^E4
with cellular keratin, E4-DBP and with mitochondria, as well as
the E1^E4-induced cell cycle arrest with respect to the viral life
cycle remains speculative. Functional analysis of E1^E4 in the
context of viral life cycle has been hindered by the lack of in
vitro system for productive viral infection and by the over-
lapping nature of the E4 and the E2 ORFs. Recent advances in
the development of model systems for papillomavirus growth,
such as organotypic raft cultures (Bedell et al., 1991; Meyers et
al., 1992) and animal papillomavirus models, such as thecottontail rabbit papillomavirus (CRPV) model (Brandsma and
Xiao, 1993), allowed the study of individual viral proteins in the
complete viral life cycle through mutagenesis (Brandsma et al.,
1991; Flores et al., 2000; Peh et al., 2004). A recent study with
CRPV showed that E1^E4 is not required for the formation of
papillomas but is required for viral DNA amplification and
capsid antigen synthesis (Peh et al., 2004). Mutational analysis
of HPV-31 E1^E4 in normal human keratinocytes grown in
semi-solid media showed reduction of viral DNA amplification
and late viral transcript levels, suggesting that E1^E4 may play
a role in viral DNA amplification and regulation of viral late
gene expression (Wilson et al., 2005).
Our previous studies demonstrate that human keratinocytes
immortalized by the catalytic subunit of human telomerase
(N-Tert) (Dickson et al., 2000), which retain normal growth and
differentiation characteristics, can support the productive stage
of the HPV-11 viral life cycle (Fang et al., 2006). In the study
presented here, we examined the role of E1^E4 in the HPV-11
viral life cycle by comparing the severely truncated form and
the wild type HPV-11 E1^E4 in the context of the whole viral
genome in N-Tert cells grown in the organotypic raft cultures.
We demonstrated that HPV-11 E1^E4 is not essential for viral
DNA amplification in the late stages of the viral life cycle.
Results and discussion
HPV-11 E1^E4 is not required for episomal DNA maintenance
in monolayer HPV-11 N-Tert cells
To examine the role of HPV-11 E1^E4 in the viral life cycle,
a single nucleotide change was introduced at position 3346, so
that the first leucine of the leucine-rich motif was changed to a
stop codon in the ORF of E4 while the overlapping E2 amino
acid sequence was unaffected. The mutant was predicted to
express a truncated E1^E4 protein consisting of the N-terminal
12 amino acids of the 90 amino acids full-length E1^E4. Two
separately derived and sequence-confirmed E1^E4 mutant
clones and the wild type plasmid (pBT-1) containing the
whole HPV-11 genome were separated from the vector by
BamHI digestion and electroporated separately into N-Tert cells
along with a neomycin resistance marker. After selection,
individual cell populations from each electroporation were
analyzed for the presence of HPV-11 DNA by Southern blot
analysis using full-length HPV-11 DNA as a probe. Results
showed that both the wild type HPV-11 N-Tert cells (W-2 and
W-6) and the HPV-11 E1^E4 mutant N-Tert cells (1-1, 1-3, 3-2
and 3-3) were able to maintain episomal copies of HPV-11
DNA (Fig. 1). Supercoiled and open circular forms of HPV-11
DNAwere detected in DNA samples that were digested with a
non-cutter of HPV-11 DNA (lanes X), and linear forms of HPV-
11 DNAwere detected in DNA samples that were digested with
a single cutter of HPV-11 DNA (lanes B) in both wild type and
HPV-11 E1^E4 mutant-clone-derived cell populations. The
copy number varies from clone to clone from approximately
300 copies to 1000 copies per cell (lanes B). The signal
intensities of undigested DNA samples (lanes X) were
consistently lower than that of their corresponding digested
Fig. 1. Detection of HPV-11 episomal DNA in HPV-11 DNA electroporated N-Tert human epithelial cells. Southern blot analysis using HPV-11 DNA as a probe for
DNA from either wild type HPV-11 (W-2 and W-6) or mutant E1^E4 HPV-11 DNA (1-1, 1-3, 3-2, 3-3) showed that electroporated N-Tert cells were digested with
either a single cutter of HPV-11, BamHI (B), or a non-cutter of HPV-11 genome, Xho (X). HPV-11 plasmid of 10 copies per cell and 100 copies per cell are shown as
controls. Supercoiled (FI), linear (FIII) and open circular DNA (FII) are shown as indicated. The size of linear HPV-11 (8 kb) is also shown as indicated.
Fig. 2. Detection of HPV-11 E1^E4 transcripts by RT-PCR analysis. Total
cellular RNA samples isolated from HPV-11 wild type (W-2 and W-6) or E1^E4
mutant (1-1, 1-3, 3-2, and 3-3) organotypic raft cultures harvested at day 10, 14
and 18 were subjected to RT-PCR analysis using nested primers for HPV-11
E1^E4. The amplification products, which are in the lower band of the two in
each lane, are shown as indicated.
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derived cell populations. This is a normal phenomenon in these
experiments. This may be due to the presence in the selected
clones of large concatemers that were unable to enter the
agarose gel for the samples digested with a non-cutter of HPV-
11 DNA and subsequently lost. Six out of six wild type and five
out of five of each mutant E1^E4 HPV-11 electroporated N-Tert
cells examined by Southern blot maintained episomal copies of
HPV-11 genome. Results indicated that HPV-11 E1^E4 is not
required for the episomal maintenance of HPV-11 DNA in
undifferentiated monolayer N-Tert cells and the E4-mutant
HPV-11 establishes itself at approximately the same frequency
as the wild type HPV-11. This result is consistent with the very
recent mutagenesis study of HPV-31 E1^E4 in transfected
human keratinocytes (Wilson et al., 2005), where mutant HPV-
31 E1^E4 genomes and wild type HPV-31 E1^E4 genomes
were maintained at copy numbers with no significant
differences.
HPV-11 E1^E4 transcripts were unaffected by the mutation in
the E4 gene
In order to check whether there is any difference in the
expression of HPV-11 E1^E4 at mRNA levels between wild
type and E1^E4 HPV-11 mutant containing organotypic raft
cultures, RNA samples isolated from both HPV-11 wild type
and E1^E4 mutant organotypic raft cultures were subjected to
RT-PCR analysis using nested primer pairs for spliced HPV-11
E1^E4 transcripts. Results showed that the same spliced E1^E4
transcripts were detected in both wild type HPV-11 and E1^E4
HPV-11 mutant raft cultures (Fig. 2). This demonstrated that the
mutation did not affect the mRNA splicing or synthesis. This
result was expected because the single nucleotide change is
designed to affect only the translation of E1^E4 mRNA
resulting in a severely truncated E1^E4 protein but not the
splicing or synthesis of E1^E4 mRNA.
Expression of HPV-11 E1^E4 protein is induced only in the
wild type HPV-11 N-Tert cells grown in raft cultures
In order to confirm the expression of HPV-11 E1^E4
protein in both wild type and the E1^E4 HPV-11 mutant N-Tert rafts, Western blot analyses using antibody specific for
HPV-11 E1^E4 protein were performed. The results indicated
that HPV-11 E1^E4 protein was only detectable in the wild
type HPV-11 N-Tert rafts at day 18 (Fig. 3B, lanes W-2 and
W-6), but not detected in any of the HPV-11 E1^E4 mutant
containing N-Tert rafts (Figs. 3A and B, lanes 1-1, 1-3, 3-2
and 3-3). This result was as expected because the single
amino acid change at position 3346 should result in a stop
codon in the E4 open reading frame, with the overlapping
E2 ORF unaffected. The severely truncated E1^E4 protein is
expected to be degraded rapidly and therefore not detected.
Since HPV-11 E1^E4 is a differentiation-induced viral late
protein, it is expected that the full-length functional E1^E4
should be present in wild type HPV-11 N-Tert rafts at day 18
when the epithelial cells are well differentiated and stratified
but not at early days when epithelial cell differentiation is
not completely achieved.
Fig. 3. Western blot analysis of protein extract isolated from HPV-11 N-Tert organotypic raft cultures. (A) One gel with protein samples from HPV-11 E1^E4
mutants N-Tert raft cultures (1-1, 1-3, and 3-2) harvested at days 10, 14 and 18 respectively as indicated. Protein extract from experimental papilloma cyst wall
(cyst) was used as a positive control as indicated. The band (E1^E4) representing HPV-11 E1^E4 is shown as indicated. (B) Another gel with protein samples from
HPV-11 E1^E4 mutant (3-3) and wild type (W-2 and W-6) N-Tert rafts harvested at days 10, 14 and 18 respectively as indicated. The positive control was the same
as in panel A.
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were unaffected by HPV-11 E1^E4 truncation
In order to examine the role of HPV-11 E1^E4 in the
viral life cycle, both wild type HPV-11 and E1^E4 HPV-11
mutant episomal DNA containing N-Tert cells were allowed
to differentiate and stratify using organotypic raft cultures.
The morphological features of papillomatous transformation
induced by both wild type HPV-11 and the E1^E4 HPV-11
mutant were examined in formalin-fixed, paraffin-embedded
and hematoxylin and eosin-stained N-Tert raft tissue sections.
Cross-section of rafts showed progressive stratification
and differentiation of epithelial cells from day 10 to day
18 (Fig. 4). More specifically, the epithelium was 4–5 cell
layers thick at day 10. The epithelium thickened signifi-
cantly from day 10 to 14 with up to 20 cell layers. Some
degree of epithelial differentiation also occurred. Occasional
koilocytes in the upper layers and some degree of
hyperplasia in parabasal layers characteristic of papillomatous
transformation were observed (Figs. 4B, E and H). By day
18, further stratification and differentiation occurred with
apparent cornification on the top of the epithelia. Koilocy-
tosis and parakaratosis characteristic of papillomatous
transformation were seen in both wild type and E1^E4
HPV-11 mutant N-Tert raft cultures (Figs. 4C, F and I).
Although there were some variation in the thickness of the
epithelia of the raft cultures, there was no apparent difference
between the morphology of the HPV-11 wild type and the
E1^E4 mutant cultures. Papillomatous transformation and
morphology were unaffected by the truncation of HPV-11
E1^E4 protein.HPV-11 E1^E4 is dispensable for HPV-11 viral DNA
amplification
To examine the role of HPV-11 E1^E4 in the viral life cycle,
we further compared the productive functions of the HPV-11
viral life cycle in N-Tert organotypic raft cultures with or
without full-length HPV-11 E1^E4. In order to make sure that
any difference that we observed was not due to random
nucleotide changes in regions other than the designed position
in E4, we used two separately derived E1^E4 mutant clones and
multiple HPV-11 episomal DNA containing cell populations for
raft cultures. In situ hybridization using an HPV-11 DNA probe
showed that viral DNA amplification was detected in both
HPV-11 N-Tert rafts with or without full-length E1^E4 at days
14 and 18. The number and intensity of positive signals varies
across each raft culture, which may be due to local variations in
the stages of differentiation and in the state and copy numbers
of the episomal HPV-11 genomes present in individual cells.
Overall, however, there was no apparent difference for the viral
DNA amplification in the presence or absence of the full-length
E1^E4. The truncated E1^E4 is expected to be non-functional
or non-expressing and acts as an E1^E4 null mutant since
functional domains, including the arrest domain and cytokeratin
association domain as well as dimmerization domain, were all
eliminated or disrupted. These results indicate that E1^E4
protein is dispensable for HPV-11 DNA amplification in our
system. Our findings differ from a recent study with cottontail
rabbit papillomavirus (CRPV), which showed that E1^E4 is
required for viral DNA amplification and capsid antigen
synthesis (Peh et al., 2004). This difference may be due to the
heterogeneity of the life cycles between CRPVand HPV. Rabbit
Fig. 4. Papillomatous transformation and stratification of HPV-11 N-Tert organotypic raft cultures. Hematoxylin and eosin staining of HPV-11 organotypic raft culture
sections. (A, B and C) HPV-11 wild type (W-2) N-Tert organotypic raft culture tissue sections harvested at days 10, 14 and 18 respectively. (D, E and F) HPV-11 E1^E4
mutant (1-3) N-Tert organotypic raft culture tissue sections harvested at days 10, 14 and 18 respectively. (G, H and I) HPV-11 E1^E4 mutant (3-3) N-Tert organotypic
raft culture tissue sections harvested at days 10, 14 and 18 respectively. Cells indicated by arrows are koilocytes.
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viral type that mostly resembles the life cycle of the mucosal
HPVs rather than CRPV (Christensen et al., 1996; Peh et al.,
2002). In addition, viral DNA amplification was occasionally
observed in the absence of E4 expression in lesions caused by
CRPV (Peh et al., 2002), suggesting that E4 may not be
absolutely required for viral DNA amplification. Southern blot
analysis of HPV-31 E1^E4 mutant or wild type genome
transfected human keratinocytes differentiated in semi-solid
media showed reduction of viral DNA amplification but not
complete abolishment of viral DNA amplification with an
E1^E4 null mutant viral genome compared to the wild type
genome (Wilson et al., 2005). However, our experiments
indicate that mutant HPV-11 E1^E4 genome amplified to a
comparable level as the wild type HPV-11 E1^E4 genome if not
more (Fig. 5), suggesting that HPV-11 E1^E4 is not required for
viral DNA amplification. The N-Tert cell line was immortalized
by the catalytic subunit of human telomerase and was deficient
in p16INK4a expression (Dickson et al., 2000). It seemed
unlikely that telomerase activity and the lack of p16INK4a could
have complemented E1^E4 function because E1^E4 has been
shown to arrest cells in the G2/M phase of the cell cycle and the
cell cycle arrest is associated with cytoplasmic retention of
cyclin B1 and CDK1 complex (Davy et al., 2005), while
p16INK4a is a CDK inhibitor of CDK4/6 and cyclin Ds that
controls G1 progression in mammalian cells (Sherr and
Roberts, 2004). Our results showed that HPV-11 E1^E4 is
dispensable for the viral life cycle in N-Tert cells grown in raft
culture. This suggests that, if E1^E4 plays a role in the HPV-11viral life cycle, it must be in late stages after viral DNA
amplification.
Materials and methods
Culture of N-Tert cell line
N-Tert cells are human foreskin keratinocytes immortalized
with the catalytic subunit of human telomerase (Dickson et al.,
2000). The N-Tert cell line was cultured in E-media (Meyers,
1996) with 5 % fetal calf serum and 5 ng/ml of epidermal
growth factor in the presence of mitomycin-C-treated J2 3T3
mouse fibroblasts feeder cells (Meyers et al., 1992). J2 3T3
mouse fibroblasts were kindly provided by Dr. Craig Meyers
(Penn State University, College of Medicine, Hershey) and were
treated with 8 μg/ml of mitomycin C (Roche Applied Science,
Indianapolis, IN) for 2–4 h at 37 °C. Treated cells were then
washed three times with PBS before trypsinization and added to
plates containing epithelial cells.
Mutagenesis of HPV-11 E1^E4
The C-terminal truncation of E1^E4 protein was constructed
in the backbone of the HPV-11 genome (HPV-11-Hershey). A
single nucleotide change (T→A) was introduced at position
3346 to generate a stop codon in the open reading frame of E4
while the overlapping E2 amino acid sequence was unaffected.
The mutant was predicted to express a truncated E1^E4 protein
of the N-terminal 12 amino acids of the 90 amino acid full-
Fig. 5. Detection of HPV-11 viral DNA amplification in HPV-11 N-Tert organotypic raft cultures. In situ hybridization of HPV-11 N-Tert organotypic raft culture tissue
sections for HPV-11 DNA. (A and B) HPV-11 wild type (W-2) N-Tert organotypic raft culture tissue sections harvested at days 14 and 18 respectively. (C and D) HPV-
11 E1^E4 mutant (1-3) N-Tert organotypic raft culture tissue sections harvested at days 14 and 18 respectively. (E and F) HPV-11 E1^E4 mutant (3-3) N-Tert
organotypic raft culture tissue sections harvested at days 14 and 18 respectively. Dark purple staining pointed by arrows are positive stained cells for HPV-11 DNA.
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QuickChange II XL site-directed mutagenesis kit (Stratagene,
La Jolla, CA), according to the manufacturer's instructions.
Primer pairs used to generate the mutant were as follows: 5′-
CGAGAAGTATCCATAGCTGAACCTACTACATACACC-3′
and 5′-GGTGTATGTAGTAGGTTCAGCTATGGATACTT-
CTCG-3′. Mutation was confirmed by sequencing the entire
region of E4 to make sure that no other nucleotide changes were
present. Multiple mutants were used for generating HPV-11
episomal DNA containing cell lines and organotypic raft
cultures to make sure that any changes observed were not due
to random mutations in the rest of the HPV-11 genome.
Establishment of HPV-11 episomal containing N-Tert cells
As previously described (McLaughlin-Drubin et al., 2003;
Meyers et al., 1992, 2002) with minor modifications, for each
electroporation, HPV-11 DNA, the pBT-1 clone of HPV-11-
Hershey, was linearized and separated from the vector
sequence by digestion with BamHI, which has a cutting site
at nucleotide 7072 in the L1 region. Linearized HPV-11 DNA
(7.5 μg), 1 μg pSV2-neo, which encodes the neomycin
resistance gene, and 42.5 μg of salmon sperm DNA, in a total
volume of 24.25 μl, were added to N-Tert cells (5 × 106) in a
volume of 250 μl of E-media containing 10% fetal bovineserum (FBS) and 5 mM N,N-bis (2-hydroxyethyl)-2-
aminoethanesulfonic acid and electroporated at 210 V and
960 μF by using the Gene Pulser Xcell (Bio-Rad Laboratories,
Hercules, CA). The electroporated cell suspension was added
to 10 ml E-media containing 10% FBS and centrifuged at
25 × g for 10 min. The resulting cell pellet was resuspended
in E-media containing 10% FBS and added to a 100 mm tissue
culture plate containing mitomycin-treated J2 3T3 feeder cells.
Cells were then selected twice with 500 μg/ml of G418 for 24 h
each time, beginning 72 h after electroporation. After the first
selection, mitomycin-treated J2 3T3 feeder cells were added
and culture was maintained for 24 h without G418 before a
second round of G418 selection was carried out. G418-resistant
cell populations grown out from a few colonies were
maintained in culture for about 1 month without further
selection until they were 70–80% confluent. The first week
after electroporation, cells were cultured in E-media with 10%
fetal calf serum and 5 ng/ml of epidermal growth factor. Cells
were then cultured in E-media with 5% fetal calf serum and
5 ng/ml of epidermal growth factor until split (70–80%
confluent). After splitting, cells were cultured in E-media with
5% fetal calf serum. Mitomycin-treated J2 3T3 feeder cells
were added as needed to cover the plate. Cell populations
containing HPV-11 DNA were identified by Southern blot
analysis.
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Epithelial raft cultures were established and maintained as
previously described (McCance et al., 1988; Meyers, 1996;
Meyers et al., 1992). Briefly, mouse fibroblasts 3T3 J-2 were
trypsinized and resuspended in 10% reconstitution buffer
(Meyers, 1996), 10% 10× DMEM (Life Technologies,
Gaithersburg, MD) (Meyers, 1996), 2.4 μl/ml 10 M NaOH
and 80% collagen to 2.1 × 105 cells/ml on ice. The mixture was
then aliquoted into 6-well plates at 3 ml per well and incubated
at 37 °C for 2–4 h to allow solidification. E-media (2 ml) was
then added to each well to allow the matrix to equilibrate.
Human epithelial cells were trypsinized and resuspended at 1 ×
106 cell/ml in E-media, and 1 ml of cell suspension was added
to each well of the 6-well plate on top of the dermal equivalent
from above. Epithelial cells were allowed to attach to the
dermal equivalent for 2–4 h. After removal of E-media,
collagen epithelia were transferred onto the grids in 100 mm
tissue culture plates using a spatula. E-media was added to the
culture plates until the media was just touching the under-side
of the collagen. Epithelial tissues were allowed to stratify and
differentiate at the air–liquid interface over 18 days. Rafts were
harvested at various time points and fixed in 10% buffered
formalin and embedded in paraffin for sectioning.
Cellular and viral DNA extraction
Cell pellets were resuspended in 3 ml of Hirt extraction
buffer containing 400 mM NaCl, 10 mM Tris–Cl, pH 7.4, and
10 mM EDTAwith a final concentration of 50 μg/ml RNase A
and 0.2% SDS. The mixtures were then incubated at 37 °C
overnight with rocking. Proteinase K was then added to a final
concentration of 50 μg/ml, and the mixtures were rocked at 37
°C for an additional 3 h. DNAwas sheared by passing through
an 18-gauge needle 10 times. DNA was then extracted twice
with an equal volume of phenol/chloroform/isoamyl alcohol
(25:24:1) and extracted once with an equal volume of
chloroform. DNA was precipitated overnight at 4 °C with 2
volumes of ethanol and 0.1 volume of 3 M NaOAc. Precipitated
DNA was centrifuged at 12,000 × g for 30 min. Pellets were
washed with 70% ethanol and dried. Pellets were then
resuspended in 100 μl TE buffer.
Southern blot analysis for HPV genome
Total DNA (5 μg) was digested with BamHI to linearize the
HPV-11 genome. XhoI, which does not cut the HPV-11
genomes, was used as a non-cut control. Enzyme digested
DNA was separated on a 0.8% agarose gel and transferred to
nitrocellulose membrane with a LKB2016-100 VacuGene
vacuum blot (Amersham Pharmacia, Piscataway, NJ) as
described by the manufacturer. The resulting membrane
was pre-hybridized in 35.6% (v/v) deionized formamide,
1× Denhardt's solution, 0.02 M NaH2PO4, 5× SSC buffer (0.75
M NaCl and 75 mM sodium citrate, pH 7) and 0.1 mg/ml
denatured and sheared salmon DNA. The HPV DNA probes
were prepared by gel purification of the 8 kb HPV cloned insertfrom recombinant vectors and labeled with the “Ready to Go”
DNA labeling kit (Amersham Pharmacia, Piscataway, NJ).
Labeled probe was purified with a ProbeQuant G50 micro-
column (Amersham Pharmacia, Piscataway, NJ). Purified probe
was denatured and added to hybridization solution containing
10% (w/v) dextran sulfate, 35.6% (v/v) deionized formamide,
1× Denhardt's solution, 0.02 M NaH2PO4 and 5× SSC buffer
(0.75 M NaCl and 75 mM sodium citrate, pH 7) and incubated
with the membrane at 46 °C overnight. Membranes were
washed 4 times with 2× SSC/0.1% SDS for 15 min each at room
temperature. The membrane was then washed twice with 0.1×
SSC/0.1% SDS for 30 min each at 50 °C and subjected to
autoradiography to detect HPV DNA.
RT-PCR analysis of HPV-11 E1^E4 transcripts
RT-PCR analysis of HPV-11 E1^E4 transcripts was
performed as described previously (Ludmerer et al., 2000;
Smith et al., 1995). Briefly, total RNA (200 ng) extracted from
infected A431 cells was reverse transcribed in the presence
of RT buffer, 5 mM MgCl2, 1 mM of dNTPs, 5 μM 11-DO
(3684GCCCAATGCCACGTTGAAGA3665) and A-DO
(1036GGAGCAATGATCTTGA TCTTC1016) primers and 2.5 U
of reverse transcriptase in a total volume of 20 μl and incu-
bated at 42 °C for 1 h. The product was amplified using
nested primer sets and two 30-cycle PCR rounds to detect the
HPV-11 E1^E4 spliced transcript. Detection of the spliced
transcript eliminated possible detection of a signal caused by
DNA contamination. β-actin primer sets were included in
PCR reactions to serve as an internal control for RNA integ-
rity. Following cDNA synthesis, primers 11-UO (778GCTGG-
GCACACTAAA TATTGT798) and A-UO (395GATGACCC
AGATCATGTTTG414) were used for 30 cycles of PCR
(temperature file: 94 °C/30 s, 60 °C/30 s, 72 °C/55 s with a
final extension of 72 °C/10 min). A portion (5 μl of 100 μl)
of the PCR reaction mixture was then utilized for a second 30
cycles of PCR primed with primers 11-UI (808CTGCGCACC-
AAAACCATAACA828), 11-DI (3578TAGGCGTAGCTG-
CACTGTGA3559 ) , A-DI (852ACTCCATGCCCAGG
AAGGAAGG831) and A-UI (423AACACCCCAGCCAT
GTACGTTG444) using the same temperature profile. PCRs
were conducted according to the manufacturer's instruction
(GeneAmp RNA PCR kit from Perkin-Elmer, Branchburg, NJ).
The final concentration of deoxynucleotide triphosphates during
PCR was 0.2 mM, and final concentrations of primers were 0.2
μM in all cases. The expected size of amplified product was 273
bp for the E1^E4 product and 429 bp for the β-actin product.
Protein extraction and Western blot analysis
Epithelial layers of organotypic raft cultures peeled from the
collagen were washed with ice-cold PBS and homogenized on
ice in 0.3 ml ice-cold Empigen BB extraction buffer containing
2% Empigen BB® (Calbiochem-Novabiochem Corporation,
San Diego, CA), 5 mM EDTA, 0.1 mM PMSF, 10 μM pepstatin
A, 10 μM leupeptin and 25 μg/ml aprotinin in PBS. Samples
were then centrifuged at 15,000 × g for 15 min at 4 °C to pellet
278 L. Fang et al. / Virology 351 (2006) 271–279insoluble debris. Supernatants containing solubilized cellular
and viral proteins were collected and stored at −70 °C. The
protein concentration of each sample was determined using the
BioRad Protein Assay (Hercules, CA). Proteins were analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to nitrocellulose membranes using
a mini transblot apparatus (Bio-Rad, Richmond, CA). Protein-
containing membranes were blocked overnight at room
temperature in 5% milk in Tris-buffered saline containing
0.1% Tween 20 (TBS-T). Primary (1473 anti-E4) and secondary
antibodies (anti-rabbit) were diluted in 5% milk in TBS-T. Each
antibody incubation time is usually 1 h to overnight. Following
each antibody incubation, membranes were washed 3 × 15 min
in TBS-T. Antibody binding was detected by enhanced
chemiluminescence (Renaissance® Western Blot Chemilumi-
nescence Reagent Plus, NEN™ Life Science Products, Inc.,
Boston, MA) with subsequent exposure to film. The anti-HPV-
11 E1^E4 (1473 anti-E4) and relevant preimmune sera were
developed by John Doorbar and were used at 1:2500 dilution for
detection of HPV-11 E1^E4 by Western blot analysis.
In situ hybridization
A biotin label was incorporated into DNA using the random
priming method (Amersham, Cleveland, OH). Deparaffinized,
rehydrated sections of formalin-fixed, paraffin-embedded
tissues were digested with pepsin (4 mg/ml in 0.1 N HCl) and
washed in Tris–HCl, pH 7.5, dehydrated and covered with a
hybridization cocktail containing 0.6 M NaCl, 10 mM Tris pH
7.4, 0.5 mM EDTA, 1 mg/ml bovine serum albumin (BSA),
0.02% polyvinylpyrrolidone (PVP) (w/v), 0.02% Ficoll (w/v),
0.15 mg/ml yeast tRNA, 5 mMDTT, 10% dextran sulfate (w/v),
50% formamide (v/v) and 1 ng/μl labeled DNA. Probe and
tissue were denatured together by heating the slides at 100 °C
for 6 min. After heat denaturation, slides were incubated in a
moist chamber at 37 °C for 2 h, washed 3 times for 10 min each
in 2× SSC (0.3 M NaCl and 30 mM sodium citrate, pH 7.0) and
incubated with avidin-conjugated alkaline phosphatase for 30
min. After washing in Tris–HCl buffer (pH 9.5) for 3 × 10 min,
the McGady reagent was used to develop signal color and
sections were counterstained with Nuclear Fast Red.
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